Merryn Voysey -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Sue Ann Costa Clemens -
Institute of Global Health, University of Siena, Siena, Italy; Department of Paediatrics, University of Oxford, Oxford, UK
Shabir A Madhi -
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Lily Y Weckx -
Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil
Pedro M Folegatti -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
PK Aley -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Brian Angus -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Vicky L Baillie -
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Shaun L Barnabas -
Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa
Qasim E Bhorat -
Soweto Clinical Trials Centre, Soweto, South Africa
Sagida Bibi -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Carmen Briner -
Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Paola Cicconi -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Elizabeth Clutterbuck -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Andrea M Collins -
Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
Clare L Cutland -
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Thomas C Darton -
Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Keertan Dheda -
Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK
Christina Dold -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Christopher J A Duncan -
Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK
Katherine R W Emary -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
K Ewer -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Amy Flaxman -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Lee Fairlie -
Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
SN Faust -
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK
D Ferreira -
Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
A Finn -
School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, UK
E Galiza -
St George's Vaccine Institute, St George's, University of London, London, UK
A Goodman -
Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK
Catherine Green -
Clinical BioManufacturing Facility, University of Oxford, Oxford, UK
Christopher A Green -
NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Melanie Greenland -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
CS Hill -
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Helen C Hill -
Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
Ian Hirsch -
AstraZeneca BioPharmaceuticals, Cambridge, UK
Alane Izu -
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Daniel Jenkin -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Carina C D Joe -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Simon Kerridge -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Anthonet Koen -
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Gaurav Kwatra -
South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
Rajeka Lazarus -
Severn Pathology, North Bristol NHS Trust, Bristol, UK
Vincenzo Libri -
NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK
Patrick J Lillie -
Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK
N Marchevsky -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Richard P Marshall -
AstraZeneca BioPharmaceuticals, Cambridge, UK
Ana V A Mendes -
Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael, Salvador, Brazil; Instituto D'Or, Salvador, Brazil
Eveline P Milan -
Universidade Federal do Rio Grande do Norte, Natal, Brazil
Angela M Minassian -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
A. M. McGregor -
London Northwest University Healthcare, Harrow, UK
Yama Mujadidi -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Anusha Nana -
Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Sherman D Padayachee -
Setshaba Research Centre, Pretoria, South Africa
Daniel J Phillips -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Ana Pittella -
Hospital Quinta D'Or, Rede D'Or, Rio De Janeiro, Brazil
Emma Plested -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
K Pollock -
NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK
Maheshi Ramasamy -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
A Ritchie -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Hannah Robinson -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Alexandre V Schwarzbold -
Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil
Andrew Smith -
College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, UK
Rinn Song -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
MD Snape -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Eduardo Sprinz -
Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
R Sutherland -
Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK
Emma C Thomson -
MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK
Mark Toshner -
Heart Lung Research Institute, Dept of Medicine, University of Cambridge and NIHR Cambridge Clinical Research Facility, Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK
David P J Turner -
University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK
Johan Vekemans -
AstraZeneca BioPharmaceuticals, Cambridge, UK
Tonya L Villafana -
AstraZeneca BioPharmaceuticals, Cambridge, UK
T White -
AstraZeneca BioPharmaceuticals, Cambridge, UK
Christopher J Williams -
Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, Wales
A Douglas -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Adrian V.S Hill -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Teresa Lambe -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
SC Gilbert -
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Andrew J. Pollard -
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk
Oxford COVID Vaccine trial group including CR:
CHRISTINE ROLLIER (Author)